Core Viewpoint - Sanyou Medical (688085.SH) reported a significant increase in revenue and net profit for the fiscal year 2025, indicating strong financial performance and effective cost management [1] Financial Performance - The company achieved total operating revenue of 542.79 million yuan, representing a year-on-year growth of 19.66% [1] - The net profit attributable to shareholders of the parent company reached 63.29 million yuan, a substantial increase of 451.85% compared to the previous year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 49.67 million yuan, marking a turnaround from loss to profit compared to the same period last year [1] Research and Development - Research and development expenses amounted to 83.71 million yuan, with R&D investment accounting for 15.42% of total revenue [1]
三友医疗(688085.SH):2025年度净利润6328.95万元,同比增加451.85%